Department of Cardiovascular Surgery, Koşuyolu High Specialization Education and Research Hospital, Koşuyolu YİEA Hastanesi, Denizer Caddesi No:2, Cevizli Kavşağı, Kartal, Istanbul, 34865, Türkiye.
Department of Anesthesia, Koşuyolu High Specialization Education and Research Hospital, Istanbul, Türkiye.
J Cardiothorac Surg. 2024 Aug 27;19(1):495. doi: 10.1186/s13019-024-03010-4.
This case report documents the first worldwide use of the Hybrid System from Spectrum Medical in a heart transplant procedure, focusing on its safety and efficacy. Traditional cardiopulmonary bypass systems often use an open reservoir, which increases the blood's exposure to air, thereby heightening the risk of an inflammatory response and gas embolism. In contrast, the Hybrid System is designed to improve surgical outcomes by significantly reducing the blood-air interface. This system utilizes a dual-chamber cardiotomy-venous reservoir with a collapsible soft bag, effectively minimizing blood contact with air and foreign materials. However, it is important to note that there is currently no evidence supporting the use of this methodology specifically in heart transplants.
A 41-year-old male managed with a left ventricular assist device because of dilated cardiomyopathy underwent a heart transplant using the Hybrid System. The perioperative and postoperative data provided evidence of the system's effectiveness. The selection of this patient was due to the absence of significant comorbidities unrelated to his primary cardiac condition, making him an ideal candidate to evaluate the system's performance.
The Hybrid System is safe and efficient. The successful implementation in this case highlights its advantages over traditional cardiopulmonary bypass systems, suggesting a promising future in cardiac surgery. Further studies with routine cardiac surgery patients are required to validate these findings.
本病例报告记录了 Spectrum Medical 公司的 Hybrid 系统在心脏移植手术中的首次全球应用，重点关注其安全性和有效性。传统的体外循环系统通常使用开放式储液器，这会增加血液与空气的接触，从而增加炎症反应和气体栓塞的风险。相比之下，Hybrid 系统旨在通过显著减少血液-空气界面来改善手术结果。该系统采用带可折叠软袋的双腔心腔-静脉储液器，有效减少血液与空气和异物的接触。然而，需要注意的是，目前尚无证据支持该方法专门用于心脏移植。
一名 41 岁男性因扩张型心肌病使用左心室辅助装置治疗，随后使用 Hybrid 系统进行心脏移植。围手术期和术后数据提供了系统有效性的证据。选择该患者是因为他没有与主要心脏状况无关的重要合并症，使其成为评估系统性能的理想人选。
Hybrid 系统是安全有效的。该系统在该病例中的成功应用突出了其相对于传统体外循环系统的优势，为心脏手术的未来发展带来了希望。需要对常规心脏手术患者进行进一步研究来验证这些发现。
